These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 11389810)

  • 1. Transitional cell carcinoma of the bladder: new approaches to the treatment of advanced disease.
    Petrylak DP
    Curr Oncol Rep; 2001 Jul; 3(4):285-6. PubMed ID: 11389810
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemotherapy for invasive bladder cancer.
    Malkowicz SB; Vaughn DJ
    Urology; 1996 Apr; 47(4):602-14. PubMed ID: 8638379
    [No Abstract]   [Full Text] [Related]  

  • 3. Combined chemotherapy and irradiation for transitional cell cancer of the bladder: a review.
    Beuzeboc P; Pontvert D; Pouillart P; Cosset JM
    J Infus Chemother; 1995; 5(4):218-20. PubMed ID: 8934733
    [No Abstract]   [Full Text] [Related]  

  • 4. [Neoadjuvant chemotherapy: meta-analysis and interpretation of results in bladder cancer].
    Pollera CF
    Suppl Tumori; 2004; 3(4):S59-61. PubMed ID: 15206215
    [No Abstract]   [Full Text] [Related]  

  • 5. Neoadjuvant chemotherapy for bladder transitional cell carcinoma: a new standard of care?
    Mazhar D; Ali N; Ngan S
    Future Oncol; 2007 Feb; 3(1):5-8. PubMed ID: 17280495
    [No Abstract]   [Full Text] [Related]  

  • 6. Neoadjuvant therapy of carcinoma of the bladder.
    deVere White RW
    Semin Urol; 1990 Aug; 8(3):197-200. PubMed ID: 2204981
    [No Abstract]   [Full Text] [Related]  

  • 7. Randomized trial of hexamethylmelamine versus 5-FU, doxorubicin, and cyclophosphamide (FAC) in advanced transitional cell bladder carcinoma: a Southwest Oncology Group study.
    Gagliano RG; Stephens RL; Costanzi JJ; Oishi N; Stuckey WJ; Grozea PN; Frank J; Crawford ED
    Cancer Treat Rep; 1984; 68(7-8):1025-6. PubMed ID: 6430559
    [No Abstract]   [Full Text] [Related]  

  • 8. Bladder cancer: management of advanced disease.
    Chong CD
    Tex Med; 1987 Feb; 83(2):51-4. PubMed ID: 3824246
    [No Abstract]   [Full Text] [Related]  

  • 9. Developing innovative strategies for advanced transitional cell carcinoma of the bladder.
    Pollera CF; Nelli F
    Expert Rev Anticancer Ther; 2006 Jan; 6(1):83-92. PubMed ID: 16375647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant chemotherapy of bladder cancer.
    Freiha FS; Torti FM
    Prog Clin Biol Res; 1988; 260():545-9. PubMed ID: 3129738
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemotherapy in the management of invasive and metastatic bladder cancer.
    Raghavan D
    Eur Urol; 1988; 14 Suppl 1():21-3. PubMed ID: 3053200
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemotherapeutic management of invasive bladder carcinoma.
    Sternberg CN; Yagoda A; Scher HI; Watson RC; Herr HW; Morse MJ; Sogani PC; Vaughan ED; Bander N; Geller N
    Eur Urol; 1988; 14 Suppl 1():19-20. PubMed ID: 3053199
    [No Abstract]   [Full Text] [Related]  

  • 13. Second-line chemotherapy in advanced bladder cancer.
    Pavone-Macaluso M; Sternberg C
    Urol Int; 2000; 64(2):61-9. PubMed ID: 10810266
    [No Abstract]   [Full Text] [Related]  

  • 14. Neo-adjuvant M-VAC chemotherapy trials in transitional cell carcinoma: perspectives for first line chemotherapy.
    Sternberg CN; Yagoda A; Scher HI; Whitmore WF; Herr HW; Morse MJ; Sogani PC; Bosl G; Watson RC; Hollander PS
    Prog Clin Biol Res; 1988; 260():551-5. PubMed ID: 3283770
    [No Abstract]   [Full Text] [Related]  

  • 15. The application of hematopoietic growth factors in advanced transitional cell carcinoma of the urinary tract.
    de Mulder PH; Sternberg CN; van Oosterom AT; Fossa SD
    Semin Oncol; 1994 Feb; 21(1 Suppl 1):65-9. PubMed ID: 7512278
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemotherapy and bladder cancer.
    Garnick MB
    J Urol; 1989 Jan; 141(1):107. PubMed ID: 2642307
    [No Abstract]   [Full Text] [Related]  

  • 17. Adjunctive adjuvant or neoadjuvant chemotherapy for locally advanced bladder cancer: a critical appraisal of the present status.
    Walther PJ
    Semin Urol; 1993 Nov; 11(4):227-34. PubMed ID: 8290828
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemotherapy of advanced bladder cancer.
    Hall RR; Roberts JT
    Prog Clin Biol Res; 1989; 303():525-31. PubMed ID: 2675009
    [No Abstract]   [Full Text] [Related]  

  • 19. Adjuvant chemotherapy for non-organ confined bladder transitional cell carcinoma.
    Abi-Aad AS
    Acta Urol Belg; 1996 May; 64(2):35-7. PubMed ID: 8701808
    [No Abstract]   [Full Text] [Related]  

  • 20. Chemotherapy for metastatic bladder cancer; the EORTC experience.
    Stoter G
    Prog Clin Biol Res; 1988; 260():471-9. PubMed ID: 3283767
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.